Inventor · disambiguated record
Neeraj Kohli
Also filed as: KOHLI NEERAJ
17 granted patents·16 pending applications·79 citations·filing 2011–2024
93Inventor score
Files withMERRIMACK PHARMACEUTICALS INC16EMMY MEDICAL LLC5IMMUNOGEN INC4JANSSEN BIOTECH INC3BAUM JASON1
Top patents by PatentIndex Score
33 records- 0195US11834498B2Biparatopic FR-alpha antibodies and immunoconjugatesIMMUNOGEN INC·Filed 2022·Granted Dec 5, 2023·2 cites·30 claims
- 0292US11396543B2Biparatopic FR-α antibodies and immunoconjugatesIMMNOGEN INC·Filed 2020·Granted Jul 26, 2022·4 cites·47 claims
- 0391US8476409B2Bispecific anti-IGF-1R and anti-ErbB3 antibodiesBAUM JASON·Filed 2012·Granted Jul 2, 2013·22 cites·15 claims
- 0489US9226964B2Antibodies against epidermal growth factor receptor (EGFR) and uses thereofMERRIMACK PHARMACEUTICALS INC·Filed 2014·Granted Jan 5, 2016·9 cites·37 claims
- 0584US9044460B2Antibodies against epidermal growth factor receptor (EGFR) and uses thereofBUKHALID RAGHIDA·Filed 2011·Granted Jun 2, 2015·9 cites·12 claims
- 0682US9458245B2ANTI-C-MET tandem Fc bispecific antibodiesMERRIMACK PHARMACEUTICALS INC·Filed 2014·Granted Oct 4, 2016·6 cites·3 claims
- 0782US2024182560A1Biparatopic fr-alpha antibodies and immunoconjugatesIMMUNOGEN INC·Filed 2023·Application pending·0 cites
- 0880US9149176B24-way cystoscopy catheterEMMY MEDICAL LLC·Filed 2014·Granted Oct 6, 2015·15 cites·20 claims
- 0979US9556274B2Monospecific and bispecific anti-IGF-1R and anti-ERBB3 antibodiesMERRIMACK PHARMACEUTICALS INC·Filed 2013·Granted Jan 31, 2017·2 cites·10 claims
- 1073US9527914B2Monospecific and bispecific anti-IGF-1R and anti-ErbB3 antibodiesMERRIMACK PHARMACEUTICALS INC·Filed 2015·Granted Dec 27, 2016·1 cites·6 claims
- 1173US2024270870A1Anti-PSMA Antibodies And Uses ThereofJANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 1272US11987641B2Anti-PSMA antibodies and uses thereofJANSSEN BIOTECH INC·Filed 2022·Granted May 21, 2024·0 cites·27 claims
- 1371USD935013SCatheterEMMY MEDICAL LLC·Filed 2021·Granted Nov 2, 2021·4 cites·1 claims
- 1465US2014234314A1Antibodies against epidermal growth factor receptor (egfr) and uses thereofMERRIMACK PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1561US10072299B2Antibodies against epidermal growth factor receptor (EGFR) and uses thereofMERRIMACK PHARMACEUTICALS INC·Filed 2015·Granted Sep 11, 2018·0 cites·21 claims
- 1661US9938346B2Monospecific and bispecific anti-IGF-1R and anti-ErbB3 antibodiesMERRIMACK PHARMACEUTICALS INC·Filed 2016·Granted Apr 10, 2018·0 cites·24 claims
- 1761US9902999B2Antibodies against epidermal growth factor receptor (EGFR) and uses thereofMERRIMACK PHARMACEUTICALS INC·Filed 2015·Granted Feb 27, 2018·0 cites·21 claims
- 1861US9885087B2Antibodies against epidermal growth factor receptor (EGFR) and uses thereofMERRIMACK PHARMACEUTICALS INC·Filed 2015·Granted Feb 6, 2018·0 cites·21 claims
- 1959US2023122503A1Anti-psma radioconjugates and uses thereofJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 2056US2019282080A1Indwelling bladder catheterEMMY MEDICAL LLC·Filed 2019·Application pending·0 cites
- 2154USD908865SCatheterEMMY MEDICAL LLC·Filed 2018·Granted Jan 26, 2021·5 cites·1 claims
- 2254US2017210809A1Bispecific binding agents targeting the igf-1r and erbb3 pathways and uses thereofMERRIMACK PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2353US2014294834A1Tandem fc bispecific antibodiesMERRIMACK PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2450US2021403594A1Epcam antibodies, activatable antibodies, and immunoconjugates, and uses thereofIMMUNOGEN INC·Filed 2019·Application pending·0 cites
- 2550US2012244163A1Bispecific binding agents targeting igf-1r and erbb3 signalling and uses thereofSCHOEBERL BIRGIT·Filed 2012·Application pending·0 cites
- 2649US10376137B2Indwelling bladder catheterEMMY MEDICAL LLC·Filed 2015·Granted Aug 13, 2019·0 cites·19 claims
- 2749US2017081421A1Anti-c-met tandem fc bispecific antibodiesMERRIMACK PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2847US2017218028A1Tandem fc bispecific antibodiesMERRIMACK PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2947US2015368361A1Antibodies against epidermal growth factor receptor (egfr) and uses thereofMERRIMACK PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3046US2016002339A1Antibodies against epidermal growth factor receptor (egfr) and uses thereofMERRIMACK PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3142US2017314079A1Antibodies against epidermal growth factor receptor (egfr) and uses thereofMERRIMACK PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 3241US2018230218A1Met antibodies and immunoconjugates and uses thereofIMMUNOGEN INC·Filed 2018·Application pending·0 cites
- 3339US2017267768A1Protein A Binding Polypeptides, Anti-EphA2 Antibodies and Methods of Use ThereofUNIV CALIFORNIA·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Neeraj Kohli files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →